Fundraising Fox
/Companies
Sign in

Kiniciti

Founded 2020 · 8 employees on LinkedIn · 3 known investors

Find your way into Kiniciti

Sign up to see every warm intro you have to Kiniciti

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Kiniciti team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

Kiniciti was founded in 2020 by Geoffrey Glass.

GGGeoffrey Glass
Geoffrey GlassFounding CEOGeoffrey Glass is founding CEO of Kiniciti, a platform company operating cell and gene therapy-focused life science businesses including Cellistic and Ncardia. He has extensive background in pharmaceutical and biotechnology product and services sectors.

Investors · 3

Welsh, Carson, Anderson & Stowe✓ confirmed by Kiniciti

How we know: the company's own site · funding news · press coverage · Not right? Tell us

WCASlisted by WCASNew York

How we know: WCAS's portfolio page · funding news · kiniciti.com · Not right? Tell us

Founder mafia

2 people who came through Kiniciti went on to found or lead other companies.

Michelle DetwilerBoard of DirectorsFounded BIOSPRING PARTNERSGeoffrey GlassFounding CEOFounded Abzena

In the news

Kiniciti raises additional capital from Biospring Partners to fund its global platform serving the Cell & Gene Therapy Industryprnewswire.com · Nov 2021Kiniciti Welcomes Two Cell and Gene Therapy Industry Leaders to its Advisory Board — KINICITIkiniciti.com · Mar 2021WCAS Commits $250M with Kiniciti, Newly-Formed Platform Investing in Cell & Gene Therapy Companies — KINICITIkiniciti.com · Feb 2021

Frequently asked questions

What does Kiniciti do?
Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.
Who founded Kiniciti?
Kiniciti was founded by Geoffrey Glass in 2020.
Who are Kiniciti's investors?
Kiniciti's investors include BIOSPRING PARTNERS, Welsh, Carson, Anderson & Stowe, WCAS.